0001127602-18-035957.txt : 20181211 0001127602-18-035957.hdr.sgml : 20181211 20181211194341 ACCESSION NUMBER: 0001127602-18-035957 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181207 FILED AS OF DATE: 20181211 DATE AS OF CHANGE: 20181211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hopkinson Craig C. CENTRAL INDEX KEY: 0001730048 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 181229864 MAIL ADDRESS: STREET 1: 852 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-12-07 0001520262 Alkermes plc. ALKS 0001730048 Hopkinson Craig C. 852 WINTER ST. WALTHAM MA 02451 1 SVP, Med Dev/Med Affairs, CMO Ordinary Shares 2018-12-07 4 A 0 4000 0 A 4881 D Ordinary Shares 2018-12-07 4 F 0 1178 34.01 D 3703 D These shares were acquired by the reporting person as a result of the partial vesting of performance-vesting restricted stock units granted to the reporting person on February 17, 2017. The vesting of this portion of the performance-vesting restricted stock units was triggered by ALKS 3831 achieving the pre-specified primary efficacy endpoints in each of two phase 3 studies. /s/ Jennifer Baptiste, attorney-in-fact for Craig C. Hopkinson 2018-12-11